The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Activity of front-line window therapy with temozolomide plus irinotecan in patients with primary multifocal Ewing sarcoma: ISG/AIEOP EW-2 protocol.
 
Asaftei Dorin Sebastian
No Relationships to Disclose
 
Nadia Puma
No Relationships to Disclose
 
Anna Paioli
Travel, Accommodations, Expenses - Lilly; Medac; PharmaMar; Takeda
Other Relationship - Eisai
 
Marco Petraz
No Relationships to Disclose
 
Carlo Morosi
No Relationships to Disclose
 
Marta Giorgia Podda
No Relationships to Disclose
 
Angela Tamburini
No Relationships to Disclose
 
Luca Coccoli
No Relationships to Disclose
 
Giovanni Grignani
Honoraria - Bayer; Eisai; Lilly; Merck Serono; Novartis; Pfizer; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Eisai; PharmaMar
Research Funding - PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar; tesaro
 
Carla Manzitti
No Relationships to Disclose
 
Rossella Bertulli
Travel, Accommodations, Expenses - Lilly; PharmaMar
 
Francesco De Leonardis
No Relationships to Disclose
 
Marco Rabusin
No Relationships to Disclose
 
Piero Picci
No Relationships to Disclose
 
Arcangelo Prete
No Relationships to Disclose
 
Alessandra Longhi
Travel, Accommodations, Expenses - Lilly
 
Franca Fagioli
Leadership - Novartis; Sanofi; Takeda
Honoraria - Jazz Pharmaceuticals; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Jazz Pharmaceuticals; Novartis; Sanofi; Takeda
Speakers' Bureau - Jazz Pharmaceuticals; Novartis; Sanofi; Takeda
Travel, Accommodations, Expenses - Jazz Pharmaceuticals; Novartis; Sanofi; Takeda
 
Roberto Luksch
No Relationships to Disclose